Abstract:Recently, we have enthusiastically read the article by Pan et al1Pan L Mu M Yang P et al.Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China: a descriptive, cross-sectional, multicenter study.Am J Gastroenterol. 2020; 115: 766-773Crossref PubMed Scopus (1209) Google Scholar that was published in Am J Gastroenterol. The authors investigated the prevalence and outcomes of COVID-19 patients with digestive symptoms, which provided useful information for us to identify the underlying patients infected with SARS-CoV-2. Here we report 3 cases in Wuhan Leishenshan Hospital with late complications (pulmonary-cerebral thrombosis, lung abscess, and pancreatitis) possibly due to SARS-CoV-2 infection to help recognize and treat COVID-19 better. Case 1: A 49-year-old man was admitted to the isolation ward with a 1-month history of fever, dry cough and shortness of breath. Eight days prior, he began to have chest pain, blood-tinged sputum and left-side hemiplegia. His viral RNA tested positive. The angiography confirmed right main pulmonary artery embolism in lower right lobe. After admission, the laboratory investigations showed leukocytosis, lymphopenia and a high D-dimer concentration (Figure 1A-C). The first chest computed tomography (CT) revealed a mass shadow of high density in the lower right lobe (Figure 1D). The CT of his brain showed right frontal lobe infarction with hemorrhagic transformation (Figure 1E, yellow arrow). Five days later, the second chest CT revealed a cavitation in condensation shadows in the lower right lobe (Figure 1F). After receiving antiviral and supportive treatment, his symptoms were gradually eased. Case 2: A 49-year-old man was admitted to the isolation ward with a nearly 2-month history of fever, cough and chest tightness. Ten days prior to admission, he began to have dyspnea. His viral RNA tested positive. He was a light smoker and had quitted smoking for many years. Because pneumothorax occurred in his right lung, a closed chest drainage was done. Eight days later he was transferred to our hospital. On the day of admission, immediate chest CT showed a lung abscess in right middle lobe (Figure 2A, yellow asterisk). Four days later, the repeated chest CT revealed that the lung abscess was fading gradually after antiviral and antibiotic treatment (Figure 2B). His fever disappeared and dyspnea was resolved gradually. Case 3: A 37-year-old man was referred to the general outpatient clinic with the complaints of abdominal pain in left upper quadrant for 5 days. The patient had no history of obesity, overeating, or staying up late. Two months earlier, the patient began to have dry cough without fever, chest distress, muscle ache or fatigue. His chest CT showed suspected viral pneumonia, then he was admitted to the isolation ward. The laboratory investigations showed elevated concentrations of amylase and lipase in his serum (Figure 3A). His viral RNA testing was negative in nasal or throat swabs, but the serum antibodies to SARS-CoV-2 were positive. The abdomen CT showed pancreatic edema with obscure fat spaces around the pancreas (Figure 3B, red arrows). After receiving antiviral and supportive treatment, his symptoms were relieved. SARS-CoV-2 binds with high affinity to human angiotensin-converting enzyme 2 (ACE2) which is used as an entry receptor to invade target cells.2Walls AC Park YJ Tortorici MA et al.Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein.Cell. 2020; 181: 281-292Abstract Full Text Full Text PDF PubMed Scopus (5963) Google Scholar It is well established that most patients with COVID-19, caused by infection with SARS-CoV-2, have fever along with respiratory signs and symptoms, such as cough and dyspnea.3Huang C Wang Y Li X et al.Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.Lancet. 2020; 395: 497-506Abstract Full Text Full Text PDF PubMed Scopus (33292) Google Scholar Herein, we reported 3 cases with late complications that presented at least 1-2 months after initial symptoms onset. The study suggested that COVID-19 might develop lung abscess, pancreatitis and thrombotic complications in the late stage. The underlying mechanism might be that the virus invades cells via binding to ACE2 and thereby causes organ damage.4Yan R Zhang Y Li Y et al.Structural basis for the recognition of the SARS-CoV-2 by full-length human ACE2.Science. 2020; 367: 1444-1448Crossref PubMed Scopus (3572) Google Scholar It is known that ACE2 is enriched in the heart, kidneys, and testes, and is also broadly distributed in the lungs, liver, intestine, and brain.5Kuba K Imai Y Ohto-Nakanishi T et al.Trilogy of ACE2: a peptidase in the renin-angiotensin system, a SARS receptor, and a partner for amino acid transporters.Pharmacol Ther. 2010; 128: 119-128Crossref PubMed Scopus (374) Google Scholar Theoretically, any human cells expressing ACE2 may be susceptible to SARS-CoV-2 infection. In case 1, it is speculated that the virus triumphed over the clearance of the immune system and invaded vascular endothelial cells through the ACE2 receptor, resulting in excessive inflammation, hypercoagulable state and thrombosis. High D-dimer concentration was common in patients with COVID-19 and might contribute to the thrombosis.6Zhou F Yu T Du R et al.Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.Lancet. 2020; 395: 1054-1062Abstract Full Text Full Text PDF PubMed Scopus (18962) Google Scholar In case 2, exhausted lymphocytes (figure not shown) could reduce immunity, thereby rendering the host susceptible to bacterial infection and abscess development because lymphocytes play a decisive role in maintaining immune homeostasis and inflammatory response throughout the body.7Tan L Wang Q Zhang D et al.Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study.Signal Transduct Target Ther. 2020; 5: 33Crossref PubMed Scopus (1142) Google Scholar In case 3, elevated levels of serum amylase and/or lipase were found in many patients with COVID-19 in Wuhan Leishenshan Hospital. We speculated two potential mechanisms leading to this abnormality.1Pan L Mu M Yang P et al.Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China: a descriptive, cross-sectional, multicenter study.Am J Gastroenterol. 2020; 115: 766-773Crossref PubMed Scopus (1209) Google Scholar The virus might directly infect the pancreatic ductal epithelial cells, resulting in cell dysfunction.2Walls AC Park YJ Tortorici MA et al.Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein.Cell. 2020; 181: 281-292Abstract Full Text Full Text PDF PubMed Scopus (5963) Google Scholar Pro-inflammatory cytokines (e.g., tumor necrosis factor α, interleukin -6) and inflammatory stress could lead to metabolic disorders in pancreas. Mechanisms mentioned above or beyond might work together to cause pancreatitis. Although the complications we report here are at a relatively low risk of occurence, clinicians should recognize these secondary diseases earlier to implement timely assessment and treatment when fighting against this pandemic.

Acute Pancreatitis with Colonic Pseudo-obstruction in a Patient with COVID-19

Acute Pancreatitis may Occur in COVID-19 Patients with Clearance of SARS-CoV-2 in Lung: A Case Report

COVID-19 presenting as acute pancreatitis

Infected Walled-Off Necrosis Following COVID-19-Associated Acute Pancreatitis

A rare case of heterotopic pancreatitis and intestinal malrotation in a COVID-19 positive patient. COVID-19, causative or coincidence?

Acute pancreatitis in COVID-19 patients: true risk?

Uncovering the Potential Pathological Mechanism of Acute Pancreatitis in Patients with COVID-19 by Bioinformatics Methods

Acute Pancreatitis As the Initial Manifestation in 2 Cases of COVID-19 in Wuhan, China

Association between Acute Pancreatitis and COVID-19: Could Pancreatitis Be the Missing Piece of the Puzzle about Increased Mortality Rates?

SARS-CoV-2 and the pancreas: What do we know about acute pancreatitis in COVID-19 positive patients?

Clinical characteristics and short-term outcomes of acute pancreatitis among patients with COVID-19

COVID-19 and acute pancreatitis: examining the causality

Determinants and outcomes of acute pancreatitis in patients hospitalized for COVID-19: Early pandemic experience

Elevated Pancreatic Enzymes in ICU Patients With COVID-19 in Wuhan, China: A Retrospective Study

Acute pancreatitis as a complication of acute COVID-19 in kidney transplant recipients

S2725 The Dual Assault of COVID-19: Hepatitis and Pancreatitis

Acute pancreatitis associated with diabetic ketoacidosis in a child with COVID-19 infection

Coronavirus Disease-19 (COVID-19) associated with severe acute pancreatitis: Case report on three family members

SARS-CoV-2 Infection: Beyond the Interstitial Pneumonia

Highly ACE2 Expression in Pancreas May Cause Pancreas Damage after SARS-CoV-2 Infection

Association Between SARS-CoV-2 Infection and Acute Ischemic Colitis